3 ms·
> Ranbaxy collapsed in 2014 due to their constant failures with the FDA [0]. Your link [0] doesn't actually support that claim, for the obvious reason that it
by thaumasiotes 3y ago
> Ranbaxy collapsed in 2014 due to their constant failures with the FDA [0].
Your link [0] doesn't actually support that claim, for the obvious reason that it isn't true. Ranbaxy didn't experience failures with the FDA. They had a stream of neverending successes punctuated by a years-long investigation that was triggered when a whistleblower emailed the FDA to reveal that Ranbaxy's data, and products, were all fraudulent.
Note that despite the whistleblower's accusations proving to be completely correct, the company did not collapse. It was acquired for a significant price.
> Well before the final resolution, in November 2011, the FDA gave its final blessing for Ranbaxy’s version of Lipitor. Asked about the decision to allow Ranbaxy to make Lipitor after its misconduct at two plants was revealed, an FDA spokesman asserts that the agency is required to evaluate a drug application on a “facility-specific basis.” The company’s “data integrity problems,” he says, occurred at facilities different from where its generic Lipitor is manufactured.
> That’s true — but it leaves out the fact that Ranbaxy originally applied to make Lipitor at one of its Indian facilities, which was then blacklisted by the FDA. The agency permitted the company to make a significant shift in its application: to switch the plant at which it would make the generic Lipitor. Ranbaxy now proposed making the drug in the U.S. at a facility that was not under FDA investigation.
> Last November [2012], Ranbaxy was back in the headlines with some very unwelcome news — the company had detected tiny glass particles in its Lipitor. It had to recall millions of pills and temporarily halt production. Says the FDA spokesperson, “The fact that there were some quality problems that led to a limited recall of the generic product was not a result of the approval process or how it was handled.”
I would not call the FDA a model of efficiency, competence, basic common sense, or honesty.
But then again, maybe the problem was the lack of an FDA Field Office in the US.
- alephnerd 3y ago2008, India's Ranbaxy shares fall 10.5 pct on U.S. probe - https://www.reuters.com/article/idUSDEL147324/ https://www.reuters.com/article/idUSDEL147324/ 2009, Daiichi to post $3 bln in losses on Ranbaxy - https://reuters.com/article/idUST336466/ https://reuters.com/article/idUST336466/ 2009, Ranbaxy slumps 16 pct as FDA says data falsified - https://www.reuters.com/article/idUSDEL443078/ https://www.reuters.com/article/idUSDEL443078/ 2013, Ranbaxy falls over 30 pct after FDA import alert; stock downgrade - https://www.reuters.com/article/idUSI8N0CZ00W/ https://www.reuters.com/article/idUSI8N0CZ00W/ 2014, Ranbaxy sale shows risk in Japanese M&A adventures - https://www.reuters.com/article/idUS1614191930/ https://www.reuters.com/article/idUS1614191930/ 2013, Ranbaxy: The Fall of an Icon - https://www.thehindubusinessline.com/news/variety/ranbaxy-fall-of-an-icon/article64565596.ece https://www.thehindubusinessline.com/news/variety/ranbaxy-fa... 2019, Former Ranbaxy owners arrested for fraud - https://www.chemistryworld.com/news/former-ranbaxy-owners-arrested-for-fraud/4010551.article https://www.chemistryworld.com/news/former-ranbaxy-owners-ar... This was a massive scandal in India at the time. It was the equivalent of if Pfizer collapsed. And it had actual ramifications in how drug regulation works in the FDA